New diabetes injection trial aims to outperform current treatment
NCT ID NCT06257966
Summary
This study is testing whether a new medication called JY09 works better than an existing drug (dulaglutide) for people with type 2 diabetes whose blood sugar isn't well controlled with metformin alone. About 600 participants will receive either JY09 at one of two doses or dulaglutide as an injection alongside their metformin for 54 weeks. Researchers will compare how well each treatment lowers blood sugar levels and monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.